Who we are and what we do
KineMed has built a drug development platform of translatable metrics that reveal the activity of key Causal Pathways in disease. These metrics are designed to be useful at essentially every step in the critical path to drug approval. KineMed's goal is to make drug development more productive and less costly. We are looking for partners in this mission and for compounds to advance, using our platform.
What are Causal Pathways in Disease and How Does KineMed Measure Them?
Causal Pathways are the biochemical processes that are responsible for driving the initiation, progression, severity or therapeutic reversal of common diseases. KineMed's repertoire of Causal Pathways metrics is based technically on cutting-edge mass spectrometric tools and captures the dynamics of targeted pathways.
Why is KineMed's Platform of Causal Pathway Activity Important in Drug Discovery and Development?
Metrics of causal pathway activity that are translatable into humans have uses at every step in the critical path to drug approval. Some examples of how these metrics can advance drug discovery and development can be seen here.
What Disease Areas Does KineMed’s Platform Cover?
KineMed's metrics of causal pathway activity include most of the common and important diseases of the modern world. Some examples of Causal Pathways in disease that KineMed measures can be seen here (and see compass, to the right).
KineMed’s Proprietary Kinetic Platform
KineMed's proprietary platform for drug development is built around two complementary innovations in molecular kinetics. To see more click here.
What can you do today to improve the productivity and reduce the cost of your Drug Discovery and Development?
|
